| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Pyxis Oncology, Inc. | Interim CEO, Director | Stock Option (Right to Buy) | 690,131 | $36,239 | $0.9800 | 03 Feb 2026 | Direct |
| Repare Therapeutics Inc. | Director | Common Shares | 0 | $0 | $2.60 | 28 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PYXS | Pyxis Oncology, Inc. | 03 Feb 2026 | 1 | $0 | 4 | Interim CEO, Director | 05 Feb 2026, 20:37 |
| RPTX | Repare Therapeutics Inc. | 28 Jan 2026 | 1 | $0 | 4 | Director | 28 Jan 2026, 20:30 |
| PYXS | Pyxis Oncology, Inc. | 31 Mar 2025 | 1 | +$36,239 | 4 | Director | 02 Apr 2025, 08:57 |
| RPTX | Repare Therapeutics Inc. | 17 Jun 2024 | 1 | $0 | 4 | Director | 20 Jun 2024, 16:35 |
| PYXS | Pyxis Oncology, Inc. | 26 Mar 2024 | 1 | +$168,612 | 4 | Director | 28 Mar 2024, 16:32 |
| RPTX | Repare Therapeutics Inc. | 08 Jun 2023 | 1 | $0 | 4 | Director | 12 Jun 2023, 16:22 |
| PYXS | Pyxis Oncology, Inc. | 24 Mar 2023 | 1 | $0 | 4 | Director | 28 Mar 2023, 16:41 |
| RPTX | Repare Therapeutics Inc. | 13 May 2022 | 1 | $0 | 4 | Director | 16 May 2022, 19:30 |
| PYXS | Pyxis Oncology, Inc. | 31 Mar 2022 | 1 | $0 | 4 | Director | 04 Apr 2022, 16:15 |
| PYXS | Pyxis Oncology, Inc. | 18 Nov 2021 | 1 | +$200,018 | 4 | Director | 19 Nov 2021, 12:21 |
| RPTX | Repare Therapeutics Inc. | 16 Nov 2021 | 1 | +$210,600 | 4 | Director | 18 Nov 2021, 16:00 |
| PYXS | Pyxis Oncology, Inc. | 07 Oct 2021 | 1 | $0 | 4 | Director | 12 Oct 2021, 19:47 |
| PYXS | Pyxis Oncology, Inc. | 07 Oct 2021 | 0 | $0 | 3 | Director | 07 Oct 2021, 21:00 |
| RPTX | Repare Therapeutics Inc. | 07 Sep 2021 | 1 | $0 | 4 | Director | 09 Sep 2021, 17:06 |
| RPTX | Repare Therapeutics Inc. | 07 Sep 2021 | 0 | $0 | 3 | Director | 09 Sep 2021, 17:05 |